Outcomes of allogeneic stem cell transplantation for patients with hematologic diseases ≥60 years old

Hematologic diseases frequently affect people >60 years old, and allogeneic stem cell transplantation (allo-SCT) is a potentially curative treatment for these patients. Although several multicenter studies proposed the risk assessment of allo-SCT for the elderly, they receive different treatments...

Descripción completa

Detalles Bibliográficos
Autores principales: Shima, Takahiro, Takigawa, Ken, Utsumi, Sae, Yoshino, Teruhiko, Naganuma, Megumi, Minami, Mariko, Hayashi, Masayasu, Matsuo, Yayoi, Kuriyama, Takuro, Eto, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Asia-Pacific Blood and Marrow Transplantation Group 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279488/
https://www.ncbi.nlm.nih.gov/pubmed/37342355
http://dx.doi.org/10.31547/bct-2022-018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10279488/
https://www.ncbi.nlm.nih.gov/pubmed/37342355
http://dx.doi.org/10.31547/bct-2022-018

Ejemplares similares